SOD1 and amyotrophic lateral sclerosis: Concurrent anomalies, including nuclear SOD1 interference with the cholinergic or other neurotransmitter phenotypes of MNs, could also be participatory, defining the selective vulnerability of lower MNs that have never been clearly identified in human ALS.